CG Products Bucket

1. Your Strategic Partner With A Global Network Of Support 5/20/2026

   With ParexelAI™, you're not just optimizing your current development timeline, you're unlocking the ability to run more programs simultaneously across our global network and compress critical timelines. In a landscape where speed to market directly impacts patient outcomes, ParexelAI empowers you to innovate and make a meaningful difference in patients' lives.

2. Portfolio Optimization Strategic Consulting 5/5/2026

   For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.

   In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.

3. iPSC Drug Discovery Platform 5/1/2026

   An iPSC drug discovery platform delivering end‑to‑end genome engineering, differentiation, and GMP transition to generate biologically relevant human cell models for efficient discovery and translation.

4. LENTIVERSE™ VectorCraft: Smarter Lentiviral Vector Design 4/29/2026

   VectorCraft is a custom lentiviral vector design and manufacturing offering for programs where complex biology is driving development and early decisions have long-term consequences.

5. LENTIVERSE™ LaunchSuite: Point‑Of‑Care CAR‑T Manufacturing 4/29/2026

   LaunchSuite is a ready‑to‑deploy point‑of‑care CAR‑T manufacturing solution for established targets, combining GMP vector supply, streamlined cell processing, and fit‑for‑purpose workflows.

6. Drug Safety And Pharmacovigilance Services 4/2/2026

   Navigating drug safety in the era of innovation-driven medicine

   The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.

7. AI In Clinical Development 4/1/2026

   What can 22,000 people with an AI-mindset accomplish?

   Speed without shortcuts

   AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

   Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:

   1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
   2. Apply insights with agility to enable better decision-making
   3. Enhance data handling to drive first-time quality through content generation and workflow automation
8. RNA Edge System 4/1/2026

   Optimizing expression of RNA therapies. Go from sequence to validated candidates in a matter of weeks.

9. Clean Blood And Tissue DNA Kit 3/26/2026

   Magnetic bead-based genomic DNA extraction kit.

10. Regulatory Affairs 3/25/2026

    In today’s clinical environment, navigating regulatory complexities isn’t optional — it’s essential.